151 related articles for article (PubMed ID: 36402922)
1. Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome unclassifiable - a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
Drozd-Sokolowska J; Gras L; Zinger N; Zahrani MA; Passweg J; Byrne J; Ho A; Huang XJ; Kröger N; Mayer J; Russo D; De Becker A; Tbakhi A; Stamatoullas A; Valerius T; Hayden P; McLornan DP; Onida F; Scheid C; Robin M; Yakoub-Agha I
Bone Marrow Transplant; 2023 Feb; 58(2):222-225. PubMed ID: 36402922
[No Abstract] [Full Text] [Related]
2. Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT.
Gurnari C; Robin M; Godley LA; Drozd-Sokołowska J; Włodarski MW; Raj K; Onida F; Worel N; Ciceri F; Carbacioglu S; Kenyon M; Aljurf M; Bonfim C; Makishima H; Niemeyer C; Fenaux P; Zebisch A; Hamad N; Chalandon Y; Hellström-Lindberg E; Voso MT; Mecucci C; Duarte FB; Sebert M; Sicre de Fontbrune F; Soulier J; Shimamura A; Lindsley RC; Maciejewski JP; Calado RT; Yakoub-Agha I; McLornan DP
Lancet Haematol; 2023 Dec; 10(12):e994-e1005. PubMed ID: 37898151
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT.
Heidenreich S; Ziagkos D; de Wreede LC; van Biezen A; Finke J; Platzbecker U; Niederwieser D; Einsele H; Bethge W; Schleuning M; Beelen DW; Tischer J; Nagler A; Glass B; Maertens J; Yáñez L; Beguin Y; Sill H; Scheid C; Stelljes M; Ganser A; Zachée P; Selleslag D; de Witte T; Robin M; Kröger N
Biol Blood Marrow Transplant; 2017 Jan; 23(1):44-52. PubMed ID: 27720995
[TBL] [Abstract][Full Text] [Related]
4. Early liver complications after allogeneic haematopoietic stem cell transplantation in patients with myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of the EBMT.
Robin M; Gras L; Koster L; Gagelmann N; van Gorkom G; Ederr M; Itälä-Remes M; Zuckerman T; Beguin Y; Schaap N; Drozd-Sokolowska J; Raj K; Hayden PJ; de Wreede LC; Battipaglia G; Polverelli N; Czerw T; Hernandez Boluda JC; Kröger N; Yakoub-Agha I; McLornan DP
Br J Haematol; 2024 Feb; 204(2):715-718. PubMed ID: 38014808
[No Abstract] [Full Text] [Related]
5. Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT.
Shimoni A; Robin M; Iacobelli S; Beelen D; Mufti GJ; Ciceri F; Bethge W; Volin L; Blaise D; Ganser A; Luft T; Chevallier P; Schwerdtfeger R; Koster L; de Witte T; Kröger N; Nagler A; Yakoub-Agha I
Br J Haematol; 2021 Nov; 195(3):417-428. PubMed ID: 34514596
[TBL] [Abstract][Full Text] [Related]
6. Impact of the International Prognostic Scoring System cytogenetic risk groups on the outcome of patients with primary myelodysplastic syndromes undergoing allogeneic stem cell transplantation from human leukocyte antigen-identical siblings: a retrospective analysis of the European Society for Blood and Marrow Transplantation-Chronic Malignancies Working Party.
Onida F; Brand R; van Biezen A; Schaap M; von dem Borne PA; Maertens J; Beelen DW; Carreras E; Alessandrino EP; Volin L; Kuball JH; Figuera A; Sierra J; Finke J; Kröger N; de Witte T;
Haematologica; 2014 Oct; 99(10):1582-90. PubMed ID: 25085359
[TBL] [Abstract][Full Text] [Related]
7. Are syngeneic donors a viable donor option in allogeneic haematopoietic cell transplantation for MDS? A brief report on behalf of the Chronic Malignancies Working Party of the EBMT and review of current literature.
Robin M; Gras L; Koster L; Saccardi R; Finke J; Forcade E; Rovira M; Kobbe G; Reményi P; Apperley J; Smaranda A; Bay JO; Casper J; de Wreede LC; Giebel S; Grillo G; Heras I; Potter V; Tischer J; Trociukas I; Nachbaur D; Drozd-Sokolowska J; Raj K; Gurnari C; Yakoub-Agha I; Onida F; Scheid C; McLornan D
Bone Marrow Transplant; 2023 Aug; 58(8):942-945. PubMed ID: 37185613
[No Abstract] [Full Text] [Related]
8. Impact of comorbidities and body mass index on the outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of EBMT.
Polverelli N; Bonneville EF; de Wreede LC; Koster L; Kröger NM; Schroeder T; Peffault de Latour R; Passweg J; Sockel K; Broers AEC; Clark A; Dreger P; Blaise D; Yakoub-Agha I; Petersen SL; Finke J; Chevallier P; Helbig G; Rabitsch W; Sammassimo S; Arcaini L; Russo D; Drozd-Sokolowska J; Raj K; Robin M; Battipaglia G; Czerw T; Hernández-Boluda JC; McLornan DP
Am J Hematol; 2024 May; 99(5):993-996. PubMed ID: 38385579
[TBL] [Abstract][Full Text] [Related]
9. Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelodysplastic/Myeloproliferative Neoplasms-Unclassifiable: A Retrospective Nationwide Study of the Japan Society for Hematopoietic Cell Transplantation.
Kurosawa S; Shimomura Y; Tachibana T; Ishiyama K; Ota S; Kobayashi T; Uchida N; Fukushima K; Ashida T; Matsuoka KI; Kanda J; Ichinohe T; Atsuta Y; Murata M; Aoki J
Biol Blood Marrow Transplant; 2020 Sep; 26(9):1607-1611. PubMed ID: 32454216
[TBL] [Abstract][Full Text] [Related]
10. Outcome of allogeneic haematopoietic cell transplantation in eosinophilic disorders: A retrospective study by the chronic malignancies working party of the EBMT.
McLornan DP; Gras L; Martin I; Sirait T; Schroeder T; Blau IW; Kuball J; Byrne J; Collin M; Stadler M; Desmier D; Salmenniemi U; Jindra P; Mikhailova N; Lenhoff S; Rifón J; Robin M; Rovira M; Veelken H; Sadowska-Klasa A; Zecca M; Hayden PJ; Czerw T; Hernández-Boluda JC; Yakoub-Agha I
Br J Haematol; 2022 Jul; 198(1):209-213. PubMed ID: 35482558
[No Abstract] [Full Text] [Related]
11. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
12. On Behalf of the SFGM-TC: Retrospective Comparison of Reduced and Higher Intensity Conditioning for High-Risk Myelodysplastic Syndrome Treated With Allogeneic Stem-Cell Transplantation.
Campidelli A; Robin M; Remen T; Luc A; Labussière-Wallet H; Dulery R; Srour M; Ceballos P; Forcade E; Nguyen-Quoc S; Furst S; Turlure P; Bay JO; Simand C; Marçais A; Daguindau E; Rubio MT; D'Aveni M
Clin Lymphoma Myeloma Leuk; 2022 Jan; 22(1):34-43. PubMed ID: 34456160
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic haematopoietic cell transplantation with reduced-intensity conditioning for elderly patients with advanced myelodysplastic syndromes: a nationwide study.
Aoki K; Ishikawa T; Ishiyama K; Aoki J; Itonaga H; Fukuda T; Kakihana K; Uchida N; Ueda Y; Eto T; Mori T; Kondo T; Iwato K; Morishima Y; Tanaka J; Atsuta Y; Miyazaki Y;
Br J Haematol; 2015 Feb; 168(3):463-6. PubMed ID: 25228239
[No Abstract] [Full Text] [Related]
14. Conditioning intensity in secondary AML with prior myelodysplastic syndrome/myeloproliferative disorders: an EBMT ALWP study.
Sengsayadeth S; Gatwood KS; Boumendil A; Labopin M; Finke J; Ganser A; Stelljes M; Ehninger G; Beelen D; Niederwieser D; Blaise D; Dreger P; Mufti G; Chevallier P; Mailhol A; Gilleece MH; Gorin N; Esteve J; Ciceri F; Baron F; Schmid C; Giebel S; Mohty M; Savani BN; Nagler A
Blood Adv; 2018 Aug; 2(16):2127-2135. PubMed ID: 30143527
[TBL] [Abstract][Full Text] [Related]
15. Progress in survival following three decades of allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: A real-world registry study in Japan.
Konuma T; Itonaga H; Ishiyama K; Hamamura A; Uchida N; Ozawa Y; Katayama Y; Sakurai M; Ueda Y; Matsuoka KI; Kawakita T; Eto T; Ara T; Kanda J; Onizuka M; Fukuda T; Atsuta Y
Am J Hematol; 2023 Apr; 98(4):E68-E71. PubMed ID: 36633538
[No Abstract] [Full Text] [Related]
16. Outcome of allogeneic stem cell transplantation for patients transformed to myelodysplastic syndrome or leukemia from severe aplastic anemia: a report from the MDS Subcommittee of the Chronic Malignancies Working Party and the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation.
Hussein AA; Halkes CM; Socié G; Tichelli A; von dem Borne PA; Schaap MN; Foa R; Ganser A; Dufour C; Bacigalupo A; Locasciulli A; Aljurf M; Peters C; Robin M; van Biezen AA; Volin L; De Witte T; Marsh J; Passweg JR; Kröger N;
Biol Blood Marrow Transplant; 2014 Sep; 20(9):1448-50. PubMed ID: 24910382
[TBL] [Abstract][Full Text] [Related]
17. A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Al-Ali HK; Brand R; van Biezen A; Finke J; Boogaerts M; Fauser AA; Egeler M; Cahn JY; Arnold R; Biersack H; Niederwieser D; de Witte T
Leukemia; 2007 Sep; 21(9):1945-51. PubMed ID: 17611571
[TBL] [Abstract][Full Text] [Related]
18. Impact of in vivo T-cell depletion in patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplant: a registry study from the Chronic Malignancies Working Party of the EBMT.
Forcade E; Chevret S; Finke J; Ehninger G; Ayuk F; Beelen D; Koster L; Ganser A; Volin L; Sengeloev H; Michallet M; Tischer J; Jindra P; Cascon MJP; Koc Y; Arat M; Tomaszewska A; Hayden P; de Witte T; Yakoub-Agha I; Kröger N; Robin M
Bone Marrow Transplant; 2022 May; 57(5):768-774. PubMed ID: 35220412
[TBL] [Abstract][Full Text] [Related]
19. Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Malignancies Working Party.
Robin M; Ruggeri A; Labopin M; Niederwieser D; Tabrizi R; Sanz G; Bourhis JH; van Biezen A; Koenecke C; Blaise D; Tischer J; Craddock C; Maillard N; Mohty M; Russel N; Schetelig J; Finke J; Gluckman E; de Witte TM; Rocha V; Kroger N
Biol Blood Marrow Transplant; 2015 Mar; 21(3):489-95. PubMed ID: 25529382
[TBL] [Abstract][Full Text] [Related]
20. Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
de Witte T; Hermans J; Vossen J; Bacigalupo A; Meloni G; Jacobsen N; Ruutu T; Ljungman P; Gratwohl A; Runde V; Niederwieser D; van Biezen A; Devergie A; Cornelissen J; Jouet JP; Arnold R; Apperley J
Br J Haematol; 2000 Sep; 110(3):620-30. PubMed ID: 10997974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
